Consequently, two mechanisms enable the [177Lu]Lu-DOTAGA-GARP probe to reach and irradiate cells in the tumour in our model: active targeting via the anti-GARP monoclonal antibody and passive targeting via the EPR effect. This evidence concerns the gene LRRC32 and neoplasm.